More on Becton Dickinson (BDX -3.8%) FQ4: net profit -3.6% to $289M, with earnings hurt by weak revenue at its biosciences and medical ops, pension settlement charges, and forex fluctuations. U.S. sales +1.2%, international -2.6%, but +7.1% excluding currency impact. Gross margin falls to 50.9% from 51.2%. Expects FY revenue growth of 2%-3% and EPS from continuing ops of $5.58-$5.64 vs consensus of +3% and $5.80.
More on Becton Dickinson (BDX -3.8%) FQ4: net profit -3.6% to $289M, with earnings hurt by weak...
From other sites
Video at CNBC.com (Aug 16, 2016)
Video at CNBC.com (May 9, 2016)
at CNBC.com (Nov 26, 2014)
at CNBC.com (Nov 4, 2014)
at CNBC.com (Oct 27, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs